Bladder Tumors and other Topics in Urological Oncology
Herausgegeben:Pavone-Macaluso, M.
Bladder Tumors and other Topics in Urological Oncology
Herausgegeben:Pavone-Macaluso, M.
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This volume is a report of the proceedings of the Second International Urological Course held in the Ettore Majorana Centre in Erice, Sicily from the 4-8 November 1978. The meeting was sponsored by the Urological Group of the EORTC (European Organisation for Research in the Treatment of Cancer), the WHO Collaborating Centre for Bladder Cancer, the European Urological Association, the Italian Research Council (CNR) , Italian League against Tumours, Italian Government and Regional Sicilian Government. Contributions were accepted on the understanding that the editors could make certain changes…mehr
Andere Kunden interessierten sich auch für
- M. A. Hayat (ed.)Methods of Cancer Diagnosis, Therapy and Prognosis147,99 €
- Methods of Cancer Diagnosis, Therapy and Prognosis166,99 €
- Robert E. SullyHistological Typing of Ovarian Tumours53,49 €
- M.A. Hayat (ed.)Methods of Cancer Diagnosis, Therapy and Prognosis221,99 €
- Methods of Cancer Diagnosis, Therapy and Prognosis251,99 €
- TNM Classification of Malignant Tumours81,99 €
- Raymond L. BarnhillPathology of Malignant Melanoma81,99 €
-
-
-
This volume is a report of the proceedings of the Second International Urological Course held in the Ettore Majorana Centre in Erice, Sicily from the 4-8 November 1978. The meeting was sponsored by the Urological Group of the EORTC (European Organisation for Research in the Treatment of Cancer), the WHO Collaborating Centre for Bladder Cancer, the European Urological Association, the Italian Research Council (CNR) , Italian League against Tumours, Italian Government and Regional Sicilian Government. Contributions were accepted on the understanding that the editors could make certain changes leading towards a uniformity of style but accepting as a priority the importance of early publication, if necessary at the expense of stylistic perfection. Editorial notes have been inserted at infrequent intervals, sometimes to summarise discussions and at others in an attempt to clarify certain issues or to highlight conflicting opinions. Although the work has been divided amongst the editors and co editors it is only proper to acknowledge that the major role in collating and in correcting much of the material has fallen on Mrs MAske who has also typed the manuscript. We should also like to acknowledge the kindness of the Yorkshire Regional Cancer Organisation who allowed Mrs Aske to devote much of her time to this work, Miss S Barrowby who has also given considerable secretarial assistance and the Department of Medical Photography, st James's University Hospital, Leeds whose staff are responsible for many of the illustrations.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Ettore Majorana International Science Series 1
- Verlag: Springer / Springer US / Springer, Berlin
- Artikelnr. des Verlages: 978-1-4613-3032-5
- Softcover reprint of the original 1st ed. 1980
- Seitenzahl: 548
- Erscheinungstermin: 26. November 2012
- Englisch
- Abmessung: 244mm x 170mm x 30mm
- Gewicht: 933g
- ISBN-13: 9781461330325
- ISBN-10: 1461330327
- Artikelnr.: 39160021
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
- Ettore Majorana International Science Series 1
- Verlag: Springer / Springer US / Springer, Berlin
- Artikelnr. des Verlages: 978-1-4613-3032-5
- Softcover reprint of the original 1st ed. 1980
- Seitenzahl: 548
- Erscheinungstermin: 26. November 2012
- Englisch
- Abmessung: 244mm x 170mm x 30mm
- Gewicht: 933g
- ISBN-13: 9781461330325
- ISBN-10: 1461330327
- Artikelnr.: 39160021
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
TNM Classification of Urological Tumors - 1978 Edition.- T Category in Renal Carcinoma.- TNM Classification in Urinary Bladder Tumors: Value of Ta Category for Noninfiltrating Exophytic Tumors.- Prednimustine.- Orgotein Efficacy in Ameliorating Side Effects Due to Radiation Therapy.- Metronidazole: A Radiosensitizer of the Hypoxic Cells.- Cis-Diammine-Dichloro-Platinum Single Drug and Combination Chemotherapy in the Treatment of Genitourinary Cancer.- The Aims and Activities of the EORTC Urological Group.- WHO Collaborating Center for Research and Treatment of Urinary Bladder and Prostatic Carcinoma.- Chemical Carcinogenesis - A Review and Personal Observations with Special Reference to the Role of Tobacco and Phenacetin in the Production of Urothelial Tumors.- Pathology of Bladder Tumors. The Urologist's Point of View.- Newer Aspects of Research in the Field of Bladder Tumors.- Cytology of Bladder Tumors - Round Table.- Scanning and Transmission Electron Microscopy of Hyperplastic and Neoplastic Human Urothelium.- In Situ Carcinoma of the Bladder.- Primary and Secondary Carcinoma-In-Situ.- Computed Tomography of Bladder Tumors.- Transrectal Ultrasonography: Staging of Bladder Tumors.- Lymphangiography in Advanced Bladder Cancer.- Clinical Significance of Urinary CEA Estimations in the Follow-Up of Patients with Bladder Carcinoma.- Glycosaminoglycans (GAG) in the Normal and Neoplastic Urinary Bladder - Preliminary Results.- Collagenase Activity in Human Bladder Cancers.- The Copenhagen Bladder Cancer Project 1968-1971.- Factors Influencing Prognosis in Patients with Bladder Tumors.- Urinary Tract Infection in Patients with Bladder Tumor.- Adenocarcinoma of the Bladder.- to Immunology and Immunotherapy of Bladder Tumors.- Immune Response in Bladder Cancer.-Monocyte Function in Bladder Cancer.- T and B Lymphocytes in Patients with Bladder Tumors.- ABH-Antigenicity in T1 Urothelial Tumors.- Humoral and Cellular Immune Response in Patients with Transitional Cell Carcinoma of the Urinary Bladder (TCC) Against Bladder Carcinoma Cells in Tissue Culture.- Immunotherapy in Bladder Cancer.- Intravesical BCG (Bacillus Calmette-Guerin) in the Management of T1 Nx Mx Transitional Cell Tumors of the Bladder: A Toxicity Study.- BCG Vaccine in the Treatment of Noninfiltrating Papillary Tumors of the Bladder.- Transurethral Surgery.- Transurethral Resection or Cystectomy? An Attempt to Answer this Question by an Evaluation of 688 Patients with Carcinoma of the Bladder (with Special Reference to Age, Sex, Stage, and the Presence of Associated Disease).- Partial Cystectomy.- Autologous Human Skin Flaps in Partial Replacement of the Bladder Wall.- Indications for Cystectomy.- The Results of Total Cystectomy for Carcinoma of the Bladder.- Radical Cystectomy in Advanced Bladder Tumors.- Cancer of the Urethra Following Cystectomy.- Supravesical Urinary Diversion.- Treatment of the Cancer of the Bladder by Irradiation, Cystoprostatectomy and Ileocystoplasty.- A Type of Rectal Pouch for Urinary Diversion After Cystectomy.- Comparison of Bricker and Wallace Methods of Ureteroileal Anastomosis in Urinary Diversion.- Lymphadenectomy in Bladder Cancer.- Effects of Intravesical Formaldehyde-Instillation (Experimental and Clinical Results).- Hydrostatic Pressure Technique and Intravesical Instillation of Formalin: Methods for the Control of Severe Bleeding from the Bladder.- Intravesical Hyperthermia for Transitional Cell Carcinoma of the Bladder.- Hyperthermia and Bladder Cancer.- Radiotherapy in the Management of Bladder Carcinoma.- Carcinoma of theBladder Category T3 Nx, 0-4 MO Treated by Preoperative Irradiation Followed by Cystectomy at the Rotterdam Radiotherapy Institute.- Surgical Treatment of 8l Deep Infiltrating Bladder Tumors after Preoperative Irradiation.- Cystectomy Following Full Course Irradiation.- Complications of Irradiation of Urological Tumors.- Post-Diversion, Pre-Cystectomy Irradiation for Transitional Cell Carcinoma of the Bladder.- Treatment of Malignant Tumors of the Bladder by Iridium 192 Wiring.- Carcinoma of the Urinary Bladder Treated by Interstitial Radium Implant.- Radioactive Source Implantation in Bladder Tumors.- Intravesical Treatment of Superficial Urinary Bladder Tumors with Adriamycin.- Intravesical Therapy with Adriamycin in Patients with Superficial Bladder Tumors.- Local Treatment of Uroepithelial Bladder Tumors with Adriamycin.- Adriamycin Therapy in Carcinoma in Situ: A Preliminary Report.- Bladder Instillation of Adriamycin in Multiple Recurrent Non-Invasive Papillomatous Bladder Tumors.- Survival in Patients Treated with Epodyl (1968-1978).- Long-Term Intracavitary Epodyl® in Multiple or Extensive Papillary Tumors of the Urinary Bladder.- Treatment of Multiple Non-Invasive Bladder Tumors with Intravesical Epodyl®.- The Treatment of Single and Multiple Papillary Tumors of the Bladder (Ta/Tl NX MO).- Adjuvant Therapy of T1 Bladder Carcinoma: Preliminary Results of an EORTC Randomized Study.- Intravesical Cis-Platinum in Bladder Tumors: Toxicity Study.- The Treatment of Bladder Cancer with Vitamin A.- The Veterans Administration Study of Chemo-Prophylaxis for Recurrent Stage I Bladder Tumors: Comparisons of Placebo, Pyridoxine, and Topical Thiotepa.- Flat Carcinoma In-Situ of the Bladder Treated by Systemic Cyclophosphamide - A Preliminary Report.- MethotrexateTherapy for Multiple Tl Category Bladder Carcinoma.- The Place of Chemotherapy in the Treatment of Patients with Invasive Carcinoma of the Bladder.- Chemotherapy in the Treatment of Invasive Bladder Cancer.- 5-Fluorouracil and Adriamycin in Locally Recurrent and/or Metastatic Bladder Cancer.- Adjuvant Chemotherapy Following Primary Irradiation in T3 Bladder Cancer.- 5-Fluorouracil in the Treatment of Recurrent Cancer of the Urinary Bladder.- Radiotherapy, Chemotherapy and Immunotherapy for Carcinoma of the Bladder.- Integrated Therapy for Invasive Bladder Carcinoma.- Cancer Chemotherapy, with Special Emphasis on the Role and Influence of Clinical Trials.- Oestrogen - Androgen Balance in Human Breast and Prostate Cancer.- Steroid Receptors in Human Prostatic Tissue.- Hormonal Receptors in Human Prostate: A Computerized Study of Normal and Pathological Tissue Samples.- Androgen Receptors in Prostatic Cancer.- Transrectal Aspiration Biopsy of the Prostate with Franzen's Instrument.- Treatment of Prostatic Cancer with Medroxyprogesterone-Acetate (MPA).- External Irradiation of Prostatic Cancer and Indicators for Failure of Treatment.- Intraurethral Irradiation of Prostatic Cancer using Afterloading Technique.- Review of the Veterans Administration Studies of Cancer of the Prostate and New Results Concerning Treatment of Stage I and II Tumors.- Estracyt.- Combined Treatment with Bleomycin in Penile Carcinoma.- Association of Surgery and Chemotherapy in Metastatic Testicular Cancer.- Speakers.
TNM Classification of Urological Tumors - 1978 Edition.- T Category in Renal Carcinoma.- TNM Classification in Urinary Bladder Tumors: Value of Ta Category for Noninfiltrating Exophytic Tumors.- Prednimustine.- Orgotein Efficacy in Ameliorating Side Effects Due to Radiation Therapy.- Metronidazole: A Radiosensitizer of the Hypoxic Cells.- Cis-Diammine-Dichloro-Platinum Single Drug and Combination Chemotherapy in the Treatment of Genitourinary Cancer.- The Aims and Activities of the EORTC Urological Group.- WHO Collaborating Center for Research and Treatment of Urinary Bladder and Prostatic Carcinoma.- Chemical Carcinogenesis - A Review and Personal Observations with Special Reference to the Role of Tobacco and Phenacetin in the Production of Urothelial Tumors.- Pathology of Bladder Tumors. The Urologist's Point of View.- Newer Aspects of Research in the Field of Bladder Tumors.- Cytology of Bladder Tumors - Round Table.- Scanning and Transmission Electron Microscopy of Hyperplastic and Neoplastic Human Urothelium.- In Situ Carcinoma of the Bladder.- Primary and Secondary Carcinoma-In-Situ.- Computed Tomography of Bladder Tumors.- Transrectal Ultrasonography: Staging of Bladder Tumors.- Lymphangiography in Advanced Bladder Cancer.- Clinical Significance of Urinary CEA Estimations in the Follow-Up of Patients with Bladder Carcinoma.- Glycosaminoglycans (GAG) in the Normal and Neoplastic Urinary Bladder - Preliminary Results.- Collagenase Activity in Human Bladder Cancers.- The Copenhagen Bladder Cancer Project 1968-1971.- Factors Influencing Prognosis in Patients with Bladder Tumors.- Urinary Tract Infection in Patients with Bladder Tumor.- Adenocarcinoma of the Bladder.- to Immunology and Immunotherapy of Bladder Tumors.- Immune Response in Bladder Cancer.-Monocyte Function in Bladder Cancer.- T and B Lymphocytes in Patients with Bladder Tumors.- ABH-Antigenicity in T1 Urothelial Tumors.- Humoral and Cellular Immune Response in Patients with Transitional Cell Carcinoma of the Urinary Bladder (TCC) Against Bladder Carcinoma Cells in Tissue Culture.- Immunotherapy in Bladder Cancer.- Intravesical BCG (Bacillus Calmette-Guerin) in the Management of T1 Nx Mx Transitional Cell Tumors of the Bladder: A Toxicity Study.- BCG Vaccine in the Treatment of Noninfiltrating Papillary Tumors of the Bladder.- Transurethral Surgery.- Transurethral Resection or Cystectomy? An Attempt to Answer this Question by an Evaluation of 688 Patients with Carcinoma of the Bladder (with Special Reference to Age, Sex, Stage, and the Presence of Associated Disease).- Partial Cystectomy.- Autologous Human Skin Flaps in Partial Replacement of the Bladder Wall.- Indications for Cystectomy.- The Results of Total Cystectomy for Carcinoma of the Bladder.- Radical Cystectomy in Advanced Bladder Tumors.- Cancer of the Urethra Following Cystectomy.- Supravesical Urinary Diversion.- Treatment of the Cancer of the Bladder by Irradiation, Cystoprostatectomy and Ileocystoplasty.- A Type of Rectal Pouch for Urinary Diversion After Cystectomy.- Comparison of Bricker and Wallace Methods of Ureteroileal Anastomosis in Urinary Diversion.- Lymphadenectomy in Bladder Cancer.- Effects of Intravesical Formaldehyde-Instillation (Experimental and Clinical Results).- Hydrostatic Pressure Technique and Intravesical Instillation of Formalin: Methods for the Control of Severe Bleeding from the Bladder.- Intravesical Hyperthermia for Transitional Cell Carcinoma of the Bladder.- Hyperthermia and Bladder Cancer.- Radiotherapy in the Management of Bladder Carcinoma.- Carcinoma of theBladder Category T3 Nx, 0-4 MO Treated by Preoperative Irradiation Followed by Cystectomy at the Rotterdam Radiotherapy Institute.- Surgical Treatment of 8l Deep Infiltrating Bladder Tumors after Preoperative Irradiation.- Cystectomy Following Full Course Irradiation.- Complications of Irradiation of Urological Tumors.- Post-Diversion, Pre-Cystectomy Irradiation for Transitional Cell Carcinoma of the Bladder.- Treatment of Malignant Tumors of the Bladder by Iridium 192 Wiring.- Carcinoma of the Urinary Bladder Treated by Interstitial Radium Implant.- Radioactive Source Implantation in Bladder Tumors.- Intravesical Treatment of Superficial Urinary Bladder Tumors with Adriamycin.- Intravesical Therapy with Adriamycin in Patients with Superficial Bladder Tumors.- Local Treatment of Uroepithelial Bladder Tumors with Adriamycin.- Adriamycin Therapy in Carcinoma in Situ: A Preliminary Report.- Bladder Instillation of Adriamycin in Multiple Recurrent Non-Invasive Papillomatous Bladder Tumors.- Survival in Patients Treated with Epodyl (1968-1978).- Long-Term Intracavitary Epodyl® in Multiple or Extensive Papillary Tumors of the Urinary Bladder.- Treatment of Multiple Non-Invasive Bladder Tumors with Intravesical Epodyl®.- The Treatment of Single and Multiple Papillary Tumors of the Bladder (Ta/Tl NX MO).- Adjuvant Therapy of T1 Bladder Carcinoma: Preliminary Results of an EORTC Randomized Study.- Intravesical Cis-Platinum in Bladder Tumors: Toxicity Study.- The Treatment of Bladder Cancer with Vitamin A.- The Veterans Administration Study of Chemo-Prophylaxis for Recurrent Stage I Bladder Tumors: Comparisons of Placebo, Pyridoxine, and Topical Thiotepa.- Flat Carcinoma In-Situ of the Bladder Treated by Systemic Cyclophosphamide - A Preliminary Report.- MethotrexateTherapy for Multiple Tl Category Bladder Carcinoma.- The Place of Chemotherapy in the Treatment of Patients with Invasive Carcinoma of the Bladder.- Chemotherapy in the Treatment of Invasive Bladder Cancer.- 5-Fluorouracil and Adriamycin in Locally Recurrent and/or Metastatic Bladder Cancer.- Adjuvant Chemotherapy Following Primary Irradiation in T3 Bladder Cancer.- 5-Fluorouracil in the Treatment of Recurrent Cancer of the Urinary Bladder.- Radiotherapy, Chemotherapy and Immunotherapy for Carcinoma of the Bladder.- Integrated Therapy for Invasive Bladder Carcinoma.- Cancer Chemotherapy, with Special Emphasis on the Role and Influence of Clinical Trials.- Oestrogen - Androgen Balance in Human Breast and Prostate Cancer.- Steroid Receptors in Human Prostatic Tissue.- Hormonal Receptors in Human Prostate: A Computerized Study of Normal and Pathological Tissue Samples.- Androgen Receptors in Prostatic Cancer.- Transrectal Aspiration Biopsy of the Prostate with Franzen's Instrument.- Treatment of Prostatic Cancer with Medroxyprogesterone-Acetate (MPA).- External Irradiation of Prostatic Cancer and Indicators for Failure of Treatment.- Intraurethral Irradiation of Prostatic Cancer using Afterloading Technique.- Review of the Veterans Administration Studies of Cancer of the Prostate and New Results Concerning Treatment of Stage I and II Tumors.- Estracyt.- Combined Treatment with Bleomycin in Penile Carcinoma.- Association of Surgery and Chemotherapy in Metastatic Testicular Cancer.- Speakers.